Hameln Pharma Ltd

  • Active
  • Large
  • 54 years
  • 29 employees
  • £15,484,501 (cur assets)
  • £27,407,580 (revenue)
  • 15m-54m
  • Regular importer
  • Regular exporter
  • Real address
  • 2 directors
  • 1 owner
  • Gloucester
  • Rating 4.0 (1)

Field of Operation

Wholesale of pharmaceutical goods
46460 4684 companies

Website

Social media

Summary

Hameln Pharma Ltd, based in Gloucester, UK, is a large, active pharmaceutical company established 53 years ago. Employing 29 people and boasting assets of £14.8 million, the company generates an annual revenue of £24.5 million. With two directors and one owner, it maintains a Google rating of 4.0 based on one review. The company regularly imports and exports pharmaceutical products, having done so for 72 and 57 months respectively.

The company’s website reveals a focus on generic injectable medicines, with a wide range of products used in hospitals and medical practices. Hameln Pharma operates globally, with companies in nine countries, including the UK, Denmark, and Australia. The website highlights the company’s commitment to quality and reliability, emphasizing its experience in the field of opioids and critical care products. It also details a robust supply chain and intelligent packaging design.

Financially, Hameln Pharma Ltd shows some concerning trends. Accrued liabilities and deferred income increased by 45%, while cash and cash equivalents dropped by a significant 64%. Bank borrowings surged by 2,400%, reaching £29,000, and cash reserves fell 30% to £28,000. On the upside, creditors decreased by 18%, suggesting better debt management. Administrative expenses rose by 57%, and the company’s net assets declined by 34%. While the company meets two of three criteria to be considered a large company, the decline in cash reserves and the rise in liabilities suggest potential financial pressures. The lack of an auditor mentioned (likely exempt as a small company) means the figures rely on unaudited statements.

Despite these challenges, Hameln Pharma’s global presence and focus on essential medicines suggest a resilient business model. The company’s commitment to quality and its wide range of products position it well to serve the healthcare industry, but it will need to address its financial trends to ensure long-term sustainability.

Registered in England/Wales under the registration number 01034697, with a registered address at GL3 4AG, Gloucester, Gloucestershire, Nexus Hurricane Road, Gloucester Business Park.

WARNING: The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.
Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Owners & PSC

  • 9 years
  • 3
  • 75%+

Managers

  • 3 years
  • 3
Managing director
  • 3 years
Ceo

Last reports

Download the last financial report
Download the last confirmation report
* may contain a full shareholder list

Last news

  1. Full accounts made up to 2024-12-31
  2. Confirmation statement made on 2025-05-13 with no updates
  3. Full accounts made up to 2023-12-31

Importer profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Import HS codes in detail

Last imported products

Click on items to see detailed UK statistics on HS code, including companies list.

* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

Exporter profile by HS codes

Click on the map to see detailed UK statistics on HS code, including companies list.

Export HS codes in detail

Last exported products

Click on items to see detailed UK statistics on HS code, including companies list.

* Warning: Ports, countries, transport, and price/kg were calculated by CorpSignals; non-official data, may contain errors.

FAQ about Hameln Pharma Ltd

Looking for leads in the UK?

Book a demo—see how CorpSignals can help you find UK leads.

Similar companies